Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can rarely cause scalp inflammation leading to hair loss, needing early detection and treatment.

Future alopecia treatments will improve with targeted therapies and personalized approaches.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Combining psychodermatology and PRP therapy can improve skin condition treatment by addressing both mental and physical health.

The FUL hair restoration technique is better for aesthetics and causes less scarring.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.

Oral minoxidil improved male baldness, but had side effects; certain antibiotics effectively treated a rare scalp condition; hair transplants might trigger another scalp condition.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Ruby laser pulses best destroy hair follicles during the growth phase and effectiveness varies with laser intensity; melanin is key for targeting, and timing treatments can improve results.

Apoptosis is crucial for healthy skin and treating skin diseases.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.